Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02723916 · ClinicalTrials.gov registry record · NA
Parent Training in Pediatric Care: A Self Directed Tablet-Based Approach
A NA study of Primary Care and Parent Training, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 287
- Enrollment target
- 1
- Study location
NCT02723916: Completed NA study of Primary Care and Parent Training, sponsored by Rush University Medical Center.
NCT02723916 is a NA study of Primary Care and Parent Training that has completed, run by Rush University Medical Center. The registered enrollment target is 287 participants, below the 60,350-participant average among 5 other Primary Care trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02723916, a NA study of Primary Care and Parent Training, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 287 participants
- Enrollment target
- 1
- Study location
Study Summary
High quality and effective parenting in the preschool years is connected with long term positive child behavior and mental health outcomes. The purpose of the study, "Parent Training in Pediatric Primary Care: A Self-directed Tablet-based Approach," is to test the outcomes and implementation of a tablet-based parent training program in Pediatric Primary Care. Testing and evaluating the implementation of digitally delivered programs is important to increase the ease, reach, sustainability, and integration of mental health prevention into primary care settings.
Primary Outcome
Measured by the Parent Questionnaire (PQ) Scale scores reported: Warmth (scale range 1-5) - higher score indicates improvement Parent Follow Through (scale range 1-5) - higher score indicates improvement Corporal punishment (scale range 1-5) - lower score indicates improvement
Conditions Studied
Interventions
- BEHAVIORAL ezParent Program
- BEHAVIORAL Health-e Kids Control App
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 287 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
What the finished NCT02723916 record still lists
NCT02723916 is an interventional study that assigns participants to a tested intervention. The registered 287 participants enrollment target is mid-sized for trials with a published cap, below the 60,350-participant average among 5 other Primary Care trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Primary Care appearing as the primary indexed condition, and to 2 interventions - of which ezParent Program is the first listed.
NCT02723916 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02723916 about?
NCT02723916 is a clinical study titled "Parent Training in Pediatric Care: A Self Directed Tablet-Based Approach". High quality and effective parenting in the preschool years is connected with long term positive child behavior and mental health outcomes. The purpose of the study, "Parent Training in Pediatric Primary Care: A Self-directed Tablet-based Approach," is to test the outcomes and implementation of a ta...
What is the current status of trial NCT02723916?
This trial is currently completed. It is a NA study. The enrollment target is 287 participants. The study started on 2015-09-01. Estimated completion is 2019-06-30.
What conditions does trial NCT02723916 study?
This clinical trial studies the following conditions: Primary Care, Parent Training.
What interventions are being tested in trial NCT02723916?
The interventions under investigation include: ezParent Program (BEHAVIORAL), Health-e Kids Control App (BEHAVIORAL).
Who is sponsoring clinical trial NCT02723916?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02723916 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Care
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Diagnostic Stewardship Intervention to Reduce Inappropriate Antibiotic Use for Urinary Tract Infections in Primary Care
RECRUITING · NA
-
Project CARE: CAncer Risk Evaluation
RECRUITING · NA
-
Arrival Time Implementation
RECRUITING · NA
-
Pilot Trial of Clinic-based Dating Violence Prevention Program for Adolescents and Caregivers
RECRUITING · NA
-
Clinic-based HIV Identification and Prevention Project Using Electronic Resources
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03094429 · 287 participants · Phase 2
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
- NCT06385080 · 287 participants · Phase 1
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- NCT06919224 · 287 participants · NA
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI